Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novo Nordisk A/S (NVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Novo Nordisk ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
99.08 -1.62    -1.61%
27/09 - Closed. Currency in USD ( Disclaimer )
After Hours
98.49
-0.59
-0.60%
18:54:43 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US6701002056 
CUSIP:  670100205
  • Volume: 719,467
  • Bid/Ask: 97.51 / 101.70
  • Day's Range: 98.85 - 99.89
Novo Nordisk ADR 99.08 -1.62 -1.61%
Period Ending: 2021
30/06
2021
31/03
2020
31/12
2020
30/09
Total Current Assets 77146 61389 65809 73667
Cash and Short Term Investments 27216 7666 12757 25480
Cash 24229 5683 12757 25480
Cash & Equivalents - - - -
Short Term Investments 2987 1983 - -
Total Receivables, Net 30223 33917 32184 28394
Accounts Receivables - Trade, Net 26098 28029 27734 24358
Total Inventory 18822 18653 18536 18105
Prepaid Expenses - - - -
Other Current Assets, Total 885 1153 2332 1688
Total Assets 158095 141387 144922 139947
Property/Plant/Equipment, Total - Net 52076 51429 50269 49925
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 20272 20357 20657 9415
Long Term Investments 1839 1749 1648 1633
Note Receivable - Long Term 413 551 674 562
Other Long Term Assets, Total 6349 5912 5865 4745
Other Assets, Total - - - -
Total Current Liabilities 72798 72384 70273 70948
Accounts Payable 7616 6800 5717 6123
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - 6684 -
Current Port. of LT Debt/Capital Leases 1301 6823 775 1468
Other Current liabilities, Total 63881 58761 57097 63357
Total Liabilities 92536 82891 81597 80374
Total Long Term Debt 12463 2832 2897 2636
Long Term Debt 12463 2832 - 2636
Capital Lease Obligations - - 2897 -
Deferred Income Tax 1818 1963 2502 991
Minority Interest - - - -
Other Liabilities, Total 5457 5712 5925 5799
Total Equity 65559 58496 63325 59573
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 462 470 470 470
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 65100 58035 63589 59788
Treasury Stock - Common -3 -9 -8 -5
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - -726 -680
Total Liabilities & Shareholders' Equity 158095 141387 144922 139947
Total Common Shares Outstanding 2272.06 2272.06 2312.5 2301.56
Total Preferred Shares Outstanding - - - -
* In Millions of DKK (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVO Comments

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jokers R Us
Jokers R Us Sep 08, 2021 3:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Name a better company
Jokers R Us
Jokers R Us Jul 27, 2021 6:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great company
David Dahan
David Dahan May 24, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
NVO WILL BUY ORMP AT 30 $
Petri Kiljunen
Petri Kiljunen Feb 16, 2021 10:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
and Gals..! :D
Petri Kiljunen
Petri Kiljunen Feb 16, 2021 10:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Guys, think about this and USA market...and market all around the world. The same Type 2 diabetes drug semaglutide seems to work well against obesity.  This can be a massive hit! https://www.fiercepharma.com/pharma/novo-nordisk-makes-headway-bid-to-rule-obesity-market-stunning-phase-3-semaglutide-data
Ralf Adams
Ralf Adams Feb 16, 2021 10:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seems that the importance of these results is being overlooked at the moment for some strange reason.  Might be a good idea to stay in long.
christopher brown
christopher brown Aug 01, 2019 1:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very good long term investment
Jorgen Andersen
Jorgen Andersen Feb 06, 2019 4:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone got a view on how much the plans to reduce medical prices will affect the share price ?
Jens Kramer
Jens Kramer Feb 06, 2019 4:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My bet is that the stock price will have an increase in growth on the long term. Not sure about short term as they might need to spend to expand production, however, they might get subsidies for this.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email